about
Complete genomic sequence of Pasteurella multocida, Pm70Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificityVaccine Adjuvants: from 1920 to 2015 and BeyondThe prodomain of the Bordetella two-partner secretion pathway protein FhaB remains intracellular yet affects the conformation of the mature C-terminal domain.Characterization of the filamentous hemagglutinin-like protein FhaS in Bordetella bronchisepticaStrain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.History of vaccinationEvidence for phenotypic bistability resulting from transcriptional interference of bvgAS in Bordetella bronchiseptica.A review of factors affecting vaccine preventable disease in Japan.Antibodies recognizing protective pertussis toxin epitopes are preferentially elicited by natural infection versus acellular immunization.Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infectiStrategies and new developments to control pertussis, an actual health problemAssessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine modelIs there a need for a new generation of vaccines against pertussis?Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthoodFilamentous hemagglutinin of Bordetella pertussis: a key adhesin with immunomodulatory properties?Reverse Vaccinology: The Pathway from Genomes and Epitope Predictions to Tailored Recombinant Vaccines.Pertussis: History of the Disease and Current Prevention Failure.Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models.XacFhaB adhesin, an important Xanthomonas citri ssp. citri virulence factor, is recognized as a pathogen-associated molecular pattern.Induction of humoral immunity in response to immunization with recombinant Mycobacterium bovis BCG expressing the S1 subunit of Bordetella pertussis toxin.Safety testing of acellular pertussis vaccines: Use of animals and 3Rs alternatives.Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
P2860
Q22066329-69E6443C-4EC7-4CA9-A34A-093B2938411CQ24535631-3DC8E820-9328-4C80-A722-1E5687D5D227Q26783879-D801439A-6CCE-4CDB-8A4A-9E7D083C7DC8Q30155214-11679DDA-C643-482E-BC61-6046E9F7F1DAQ33946514-0FDCD268-833A-49F2-B203-05336DF1C29FQ34041933-64FDB95D-65D5-4CAA-9528-CFC5D778374DQ34119899-05293D14-4440-4357-9110-AC6D0C0BDDD1Q34438161-1A467376-ADD5-4D5C-8E4A-FA6A96240E0AQ34990738-0FB45DAB-8AED-434B-A8BA-9B60B604FEECQ35066448-0DED0DFA-073E-45A8-B891-C4D72303A758Q35951021-533E6940-C115-4B51-A724-1B271EE32847Q36174557-B3023963-C703-466A-BBEC-AD986F4498FEQ36226470-AA1134B1-2FD1-4EFC-8056-04E85CA0D4E5Q36334703-515E5B05-7C48-46E0-84E9-3083734EBAF1Q36458388-E37512AA-BFB9-475F-8208-195963B840C7Q36984668-566A3EA4-03B6-49CC-87E8-E980588B7726Q38291883-9F4F6B91-CCA6-4ABD-936E-7AB549DED22BQ38807834-5250D074-B0B0-4EE0-A412-7C5AE6F06658Q38852136-8DEE9499-EEA0-465B-9671-489BD5C3815EQ40497346-8BBFC080-5B4E-4ACB-B383-93682DF59381Q42486970-F75C6998-85D4-44D2-B6D7-33AA68FDFA08Q43856255-7D35F079-349C-4741-AEA5-F1D7C33760CAQ47139846-AA3C5AD8-2038-407D-8722-C8210313C466Q54208973-FC241C57-079F-4847-9920-88276D396EC4Q56795571-52DA4FC3-823E-4152-8E4A-2E72C4083FAD
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Development of acellular pertussis vaccines.
@ast
Development of acellular pertussis vaccines.
@en
type
label
Development of acellular pertussis vaccines.
@ast
Development of acellular pertussis vaccines.
@en
prefLabel
Development of acellular pertussis vaccines.
@ast
Development of acellular pertussis vaccines.
@en
P356
P1433
P1476
Development of acellular pertussis vaccines.
@en
P356
10.1006/BIOL.1999.0181
P577
1999-06-01T00:00:00Z